Thomas R. de Wijkerslooth

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra et al. · Nature Medicine · 2020 · 1.4K citations · Full text

Medicine, Oncology, Pathology +14

Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial

Esther M. Stoop, Margriet C. de Haan, Thomas R. de Wijkerslooth et al. · The Lancet Oncology · 2011 · 369 citations

Medicine, Oncology, Radiology +16

Immunochemical Fecal Occult Blood Testing Is Equally Sensitive for Proximal and Distal Advanced Neoplasia

Thomas R. de Wijkerslooth, Esther M. Stoop, Patrick M. Bossuyt et al. · The American Journal of Gastroenterology · 2012 · 205 citations

Medicine, Oncology, Preventive Medicine +17

Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time

Thomas R. de Wijkerslooth, Esther M. Stoop, Patrick M. Bossuyt et al. · Gastrointestinal Endoscopy · 2013 · 158 citations

Medicine, Pharmacokinetics, Pharmacokinetic Variability +6

Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy

Inge Stegeman, Thomas R. de Wijkerslooth, Esther M. Stoop et al. · Gut · 2013 · 112 citations · Full text

Medicine, Biostatistics, Preventive Medicine +16